William G. Rice - 16 Dec 2021 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role: Chair, President & CEO, Director
Signature: /s/ Janet Clennett, attorney-in-fact for William G. Rice
Issuer symbol: APTOF
Transactions as of: 16 Dec 2021
Net transactions value: +$20,038
Form type: 4
Filing time: 17 Dec 2021, 12:38:57 UTC
Previous filing: 15 Dec 2021
Next filing: 20 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APTO	Common Shares	Purchase	$20,038	+13,183	+4%	$1.52	343,252	16 Dec 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.50 to $1.152, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.50 to $1.152, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.